Latvija - latviešu - Zāļu valsts aģentūra

strides pharma (cyprus) limited, cyprus - alfakalcidols - kapsula, mīkstā - 0,25 µg

Latvija - latviešu - Zāļu valsts aģentūra

strides pharma (cyprus) limited, cyprus - alfakalcidols - kapsula, mīkstā - 0,5 µg

Latvija - latviešu - Zāļu valsts aģentūra

strides pharma (cyprus) limited, cyprus - alfakalcidols - kapsula, mīkstā - 1 µg

Latvija - latviešu - Zāļu valsts aģentūra

strides pharma (cyprus) limited, cyprus - gabapentīns - kapsula, cietā - 100 mg

Latvija - latviešu - Zāļu valsts aģentūra

strides pharma (cyprus) limited, cyprus - gabapentīns - kapsula, cietā - 300 mg

Latvija - latviešu - Zāļu valsts aģentūra

strides pharma (cyprus) limited, cyprus - gabapentīns - kapsula, cietā - 400 mg

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcija homeostāze - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.

Latvija - latviešu - Pārtikas un veterinārais dienests, Zemkopības ministrija

dechra veterinary products a/s, dānija - dietanolamīnu fusidate, framycetin sulfāts, nistatīns, prednizolons - ausu pilieni, suspensija - kaķi; suņi

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

taw pharma (ireland) limited - klopidogrela hidrohlorīds - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - antitrombotiskie līdzekļi - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

Eiropas Savienība - latviešu - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin propāndiols monohidrāts - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - cukura diabēts - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. papildus citām zālēm, lai ārstētu 2. tipa cukura diabētu. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 un 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.